Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Patented Cannabinoid Delivery System Approved
Patented lipophilic delivery system increases bio-absorption Patents cover broad range of lipophilic bio-actives, including cannabinoids, vitamins, other pharma 19 patents filed across 44 countries First international patent issued and approved in Australia Any argument over the efficacy of medicinal marijuana is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://nnw.fm/7HnBi). However, the human gastrointestinal tract just doesn’t absorb cannabinoids effectively, and much of what is ingested is simply excreted by the body. Subsequently, onset times and effectiveness vary wildly. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB:…